Science Explorer Back to mapMap
Discussion
Researcher · Centre Hospitalier Sud Francilien · France

Bertrand Joly

Bertrand Joly publishes mostly in Pathology and Forensic Medicine, Oncology and Hematology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Viral-associated cancers and disorders.

ORCID 0000-0002-4136-9002 OpenAlex
World rank
#540,237
of 7,710,434 ranked researchers
Rank in France
#27,926
of 324,115
Works
92
Citations
2.7k
Citations per work
29.3
h-index
22
i10-index 31Top 23% in Pathology and Forensic Medicine
Bertrand Joly

What does Bertrand Joly research?

Bertrand Joly's work is mostly in Medicine (43%), Arts and Humanities (8%), Social Sciences (5%).

Everything else: 40 works · 43.6% of their workHealth Sciences: 39 works · 42.8% of their workMedicine: 39 works · 42.8% of their workPathology and Forensic Medicine: 13 works · 13.6% of their workOncology: 11 works · 12.3% of their workHematology: 9 works · 9.3% of their workGenetics: 7 works · 7.6% of their workSocial Sciences: 13 works · 13.6% of their workArts and Humanities: 8 works · 8.5% of their workHistory: 8 works · 8.5% of their workSocial Sciences: 5 works · 5.1% of their workPolitical Science and International Relations: 5 works · 5.1% of their workTHEIR WORKBertrand Joly92works
Health Sciences43%Social Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else4043.6%
    1. Medicine3942.8%
    1. Arts and Humanities88.5%
    2. Social Sciences55.1%
  1. 1Pathology and Forensic Medicine14% of their works
  2. 2Oncology12% of their works
  3. 3Hematology9% of their works
  4. 4History8% of their works
  5. 5Genetics8% of their works
  6. 6Political Science and International Relations5% of their works

Research topics

Which keywords describe Bertrand Joly's research?

The keywords of their largest research topics: Rituximab, Classification, Lymphoma, Resistance, Chronic Lymphocytic Leukemia, Genomic Aberrations, Epstein-Barr Virus and France.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Rituximab462 topics
  2. Classification301 topic
  3. Lymphoma301 topic
  4. Resistance192 topics
  5. Chronic Lymphocytic Leukemia161 topic
  6. Genomic Aberrations161 topic
  7. Epstein-Barr Virus121 topic
  8. France121 topic
  9. History121 topic
  10. Kaposi's Sarcoma121 topic
  11. Scientific History121 topic
  12. Technological Development121 topic
  13. Diagnosis Criteria91 topic
  14. International Myeloma Working Group91 topic
  15. BCR-ABL71 topic
  16. French Revolution71 topic
  17. Imatinib71 topic
  18. Napoleonic Wars71 topic

Where does Bertrand Joly work?

Bertrand Joly's main affiliation in the publication record is Centre Hospitalier Sud Francilien, France.

How many publications and citations does Bertrand Joly have?

OpenAlex counts 92 works and 2,699 citations for Bertrand Joly, an h-index of 22, ranking #540,237 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Bertrand Joly

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Bertrand Joly. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.